about
Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathwayRegulation and roles of PI3Kβ, a major actor in platelet signaling and functionsNovel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli CellsThe emerging mechanisms of isoform-specific PI3K signallingPancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110αMolecular signaling of somatostatin receptors.Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Loss of p27Kip¹ promotes metaplasia in the pancreas via the regulation of Sox9 expressionThe p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.Somatostatin analogs: does pharmacology impact antitumor efficacy?Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ.Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-independent translation-mediated mechanism.Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis.Targeting PI3K Signaling in Combination Cancer Therapy.Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways.Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons.Restoring hemidesmosomes to prevent cancer cell invasiveness.Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?Increase in PI3K signalling mimics mutated-Kras induction of pancreatic cancer.Nucleolin Promotes Heat Shock-Associated Translation of VEGF-D to Promote Tumor Lymphangiogenesis.Lymphatic Vasculature Requires ER (Estrogen Receptor)-α Signaling to Protect From Lymphedema.Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance.Deletion of the p110 isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivoLaser-assisted 3D bioprinting of exocrine pancreas spheroid models for cancer initiation studyExperimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elasticity imagingeIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancerPaclitaxel induces lymphatic endothelial cells autophagy to promote metastasis
P50
Q24300160-604A011F-3A31-488A-9BCB-98590379B21EQ24305005-B37E0881-A00B-46CB-8ECC-94E7971487F0Q28546072-8DE4185A-08EE-4F36-81F7-5596CC06811CQ29617954-6999CCC7-F05D-4C45-9BB7-68469E7DDCE4Q34590266-019088DB-00EF-4939-B993-DE7770EE37C8Q35778257-1AF9F248-DE27-4065-8D64-B2459EAF6183Q36443870-7BA137EC-43AA-40F9-A273-3CFE7AA7D59CQ36546501-5899260A-8E7F-4465-A00E-7C490DD3F910Q36751486-DE9D01CD-05ED-48FD-8552-9BFB7DC570CAQ38177033-FB574F79-D578-48B8-9FB8-331C9DB01C30Q38545781-8CD68D89-D7FF-4AA6-8562-0EE957294633Q38742488-81DCABAE-DA23-4190-A2C1-35ECF7DDD413Q39037560-61AF3A5A-E0AC-43E8-B61F-CF5135431C2DQ39094806-DD3EA168-7013-49E7-B5BA-17B56164427EQ39441303-EC7D992B-FCD5-47E2-A616-C9F71224D576Q40726891-6D69F381-7064-4320-BBC0-916443392AB0Q41791633-5782C5EE-3A9B-4034-8A40-56C9D1E95DB8Q42802804-ED0E0FE8-B590-4A0C-824B-F89E6DBC3886Q42937219-1A7DD622-F356-4B42-8F64-DEC495043F89Q42962716-A9250DAE-5DEC-4728-90CC-3D65838F3DD4Q46048012-8B2694CF-3567-4474-9AB9-E2B2DBB1AF21Q50195654-4F1FF376-2469-420E-BCDE-3D65ADDB6794Q50927647-96479C2B-56BC-446D-91F2-27AB26055943Q51712051-A5F61066-3731-446B-8423-7A7D61345A7DQ52591092-376A13D1-CFF0-44AB-AE52-C7E16B065E71Q54977145-06C56525-0E43-492D-A880-480C09B5E017Q55274845-0A3C8D47-220E-4C5E-9C4F-9628E8130686Q61562523-4BA0C073-BE54-400F-9C19-DB1A7A38592BQ90045392-1C2E5439-AE53-4680-878E-2BCFD5688824Q90533132-D6750057-26B7-41A5-BE51-FAB3CB564DA0Q91044608-7EE98C5E-973B-4843-B254-FF0044BD3F23Q92163838-5833F5DF-90C7-41E2-AA75-57D21DBC693B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Julie Guillermet-Guibert
@ast
Julie Guillermet-Guibert
@en
Julie Guillermet-Guibert
@es
Julie Guillermet-Guibert
@nl
Julie Guillermet-Guibert
@sl
type
label
Julie Guillermet-Guibert
@ast
Julie Guillermet-Guibert
@en
Julie Guillermet-Guibert
@es
Julie Guillermet-Guibert
@nl
Julie Guillermet-Guibert
@sl
prefLabel
Julie Guillermet-Guibert
@ast
Julie Guillermet-Guibert
@en
Julie Guillermet-Guibert
@es
Julie Guillermet-Guibert
@nl
Julie Guillermet-Guibert
@sl
P1053
D-2317-2014
P106
P1153
8847067100
P21
P31
P3829
P496
0000-0003-3173-4907